This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 195
of 2 
Show all 195
Data pager
Data pager
12
 Item 1 to 99 of 195
of 2 
Show all 195
Monday, April 12 | 3:00PM - 7:00PM
Registration
Room: Grand Foyer


Monday, April 12 | 6:15PM - 7:15PM
Refreshments
Room: Grand Foyer


Monday, April 12 | 7:15PM - 7:30PM
Orientation
Room: Ballroom B, C


Monday, April 12 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Ballroom B, C

Speaker 1 of 3
* Norman L. Letvin, Beth Israel Deaconess Medical Center, USA

Monday, April 12 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Ballroom B, C

Speaker 2 of 3
Gary J. Nabel, Sanofi, USA
The Critical Path to an Effective AIDS Vaccine

Monday, April 12 | 7:30PM - 9:30PM
Keynote Session (Joint)
Room: Ballroom B, C

Speaker 3 of 3
Wesley I. Sundquist, University of Utah School of Medicine, USA
The Biochemistry of HIV-1 Release

Tuesday, April 13 | 6:30AM - 8:00AM
Breakfast
Room: Lower Level


Tuesday, April 13 | 8:00AM - 11:00AM
HIV Entry Mechanisms and Neutralizing Antibodies (Joint)
Room: Ballroom B, C

Speaker 1 of 6
* Joseph G. Sodroski, Dana-Farber Cancer Institute, USA
Innate Intracellular Immunity to HIV-1 in Old World Monkeys

Tuesday, April 13 | 8:00AM - 11:00AM
HIV Entry Mechanisms and Neutralizing Antibodies (Joint)
Room: Ballroom B, C

Speaker 2 of 6
David C. Montefiori, Duke University Medical Center, USA
Neutralizing Antibodies Induced by Candidate HIV-1 Vaccines

Tuesday, April 13 | 8:00AM - 11:00AM
HIV Entry Mechanisms and Neutralizing Antibodies (Joint)
Room: Ballroom B, C

Speaker 3 of 6
Alexandra Trkola, University of Zürich, Switzerland
Antibodies: Surrogate or Supporter of Protective Immunity?

Tuesday, April 13 | 8:00AM - 11:00AM
HIV Entry Mechanisms and Neutralizing Antibodies (Joint)
Room: Ballroom B, C

Speaker 4 of 6
Susan Zolla-Pazner, Icahn School of Medicine at Mount Sinai, USA
The V3 Loop: Always Changing, Always the Same

Tuesday, April 13 | 8:00AM - 11:00AM
HIV Entry Mechanisms and Neutralizing Antibodies (Joint)
Room: Ballroom B, C

Speaker 5 of 6
Gregory B. Melikian, Emory University, USA
Short Talk: Dissecting the Steps of HIV ENV-Induced Fusion: Coreceptor Engagement, Fusion Pore Formation, and Pore Enlargement

Tuesday, April 13 | 8:00AM - 11:00AM
HIV Entry Mechanisms and Neutralizing Antibodies (Joint)
Room: Ballroom B, C

Speaker 6 of 6
James Mark Binley, San Diego Biomedical Research Institute, USA
Short Talk: Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-HIV Monoclonal Antibodies and a Clade B HIV+ Plasma

Tuesday, April 13 | 9:20AM - 9:40AM
Coffee Break
Room: Grand Foyer


Tuesday, April 13 | 11:00AM - 1:00PM
Poster Setup
Room: Ballroom A, Grand Foyer


Tuesday, April 13 | 1:00PM - 10:00PM
Poster Viewing
Room: Ballroom A, Grand Foyer


Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 1 of 9
* Wesley I. Sundquist, University of Utah School of Medicine, USA
Following the RNA

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 2 of 9
Melanie M. Ott, Gladstone Institutes, USA
SIRT1 Deacetylates the HIV Tat Protein and is Required for Tat-Mediated Transactivation of the HIV Promoter

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 3 of 9
Roger J. Pomerantz, Seres Therapeutics, Inc., USA
A Dead Box Protein is as a Critical Cellular Co-Factor of HIV-1 REV: Effects on Viral Persistence and Reservoirs in Different Cell-Types

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 4 of 9
Chad M. Swanson, King's College London, UK
A Link between Viral Assembly and Nuclear Export

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 5 of 9
Andrew J. Mouland, McGill University, Lady Davis Institute, Canada
The Specific Association of hnRNP A2 to its Cognate Response Sequence in HIV-1 RNA Implications in Viral Assembly

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 6 of 9
Heinrich Göttlinger, Dana Farber Cancer Institute, USA
Roles of AIP1 and ESCRT-III in HIV Budding

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 7 of 9
Marc C. Johnson, Cornell University, USA
Visual Comparison of Retroviral Late-Domain Phenotypes

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 8 of 9
Rebecca J. Loomis, University of North Carolina at Chapel Hill, USA
Citron Kinase, a RhoA Effector, Enhances HIV-1 Virion Release

Tuesday, April 13 | 2:00PM - 4:00PM
Workshop 1: HIV Accessory Protein and Assembly
Room: Garibaldi A/B
Attendance Limited to 125
Speaker 9 of 9
Vicente Planelles, University of Utah, USA
The Mechanisms of HIV-1 VPR-Mediated G2 Arrest and Apoptosis: Role of the Host Cell DNA Damage Signaling Pathway

Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 1 of 10
* Richard T. Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute, USA


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 2 of 10
Barna Dey, NIAID, National Institutes of Health, USA
Characterization of Mutant HIV-1 Envelope Glycoproteins Stabilized in the CD4-Bound Conformation


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 3 of 10
Kathy P. Fernando, University of Pennsylvania, USA
HIV Env Lacking CD4 Binding as a Vaccine Approach


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 4 of 10
Marie Pancera, Fred Hutchinson Cancer Research Center, USA
Characterization of Stabilized Trimeric HIV-1 gp120 Envelope Glycoprotein


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 5 of 10
Suganya Selvarajah, The Scripps Research Institute, USA
Modified gp140 Trimers to Elicit b12-Like Antibodies


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 6 of 10
Chinglai Yang, Emory University, USA
Characterization of an HA/Gp41 Chimeric Protein: Enhanced Interaction with the Broadly Neutralizing Monoclonal Antibody 2F5 against HIV


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 7 of 10
Jason E. Hammonds, Emory University, USA
Induction of Antibody Responses to CD4-Induced Epitopes by Induced Pseudovirions and Recombinant Protein Immunogens


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 8 of 10
Jonathan M. Gershoni, Tel Aviv University, Israel
Backtracking from mAb to Epitope - A Combinatorial Approach


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 9 of 10
Carolina Herrera, Imperial College, UK
Consequences of HIV-1 Env Cleavage on Antigenicity, Infectivity, and Neutralization


Tuesday, April 13 | 2:00PM - 4:15PM
Workshop 1: HIV Envelope Structure and Neutralization
This session is from HIV Vaccine
Room: Ballroom B, C

Speaker 10 of 10
Gerald V. Quinnan, Jr., Uniformed Services University Health Sciences, USA
Protection Against Rhesus Monkey Adapted-SHIV Challenge by Active Induction of HIV-1 Neutralizing Antibodies or SIV gag-Specific Cytotoxic T Cells


Tuesday, April 13 | 4:30PM - 4:45PM
Coffee & Snacks Available
Room: Grand Foyer


Tuesday, April 13 | 4:45PM - 7:00PM
Natural SIV Infection: Lessons from the Monkey (Joint)
Room: Ballroom B, C

Speaker 1 of 5
* Paul M. Sharp, University of Edinburgh, UK
Evolution from SIV to HIV

Tuesday, April 13 | 4:45PM - 7:00PM
Natural SIV Infection: Lessons from the Monkey (Joint)
Room: Ballroom B, C

Speaker 2 of 5
Beatrice H. Hahn, University of Pennsylvania, USA
Molecular Epidemiology of Simian Immunodeficiency Virus Infection in Wild Chimpanzees

Tuesday, April 13 | 4:45PM - 7:00PM
Natural SIV Infection: Lessons from the Monkey (Joint)
Room: Ballroom B, C

Speaker 3 of 5
Mark B. Feinberg, IAVI International AIDS Vaccine Initiative, USA
Host-Virus Relationships Underlying Non-Pathogenic SIV Infections


Tuesday, April 13 | 4:45PM - 7:00PM
Natural SIV Infection: Lessons from the Monkey (Joint)
Room: Ballroom B, C

Speaker 4 of 5
Greg J. Towers, University College London, UK
Short Talk: Species-Specific Infection of Lentiviruses

Tuesday, April 13 | 4:45PM - 7:00PM
Natural SIV Infection: Lessons from the Monkey (Joint)
Room: Ballroom B, C

Speaker 5 of 5
Nathaniel R. Landau, New York University School of Medicine, USA
Short Talk: Mechanism of APOBEC3G Deamination of HIV Reverse Transcripts

Tuesday, April 13 | 7:00PM - 8:00PM
Social Hour
Room: Ballroom A, Grand Foyer


Tuesday, April 13 | 7:30PM - 10:00PM
Poster Session 1
Room: Ballroom A, Grand Foyer


Wednesday, April 14 | 6:30AM - 8:00AM
Breakfast
Room: Lower Level


Wednesday, April 14 | 8:00AM - 11:00AM
HIV Genome RNA: From the Nucleus to the Plasma Membrane
Room: Ballroom C

Speaker 1 of 5
* Tristram G. Parslow, Emory University, USA
The HIV-1 Genomic Dimer Interface as a Target for Structure-Based Drug Design

Wednesday, April 14 | 8:00AM - 11:00AM
HIV Genome RNA: From the Nucleus to the Plasma Membrane
Room: Ballroom C

Speaker 2 of 5
Kathleen A. Boris-Lawrie, Ohio State University, USA
The Destiny of Retroviral Unspliced RNA: Ribosome or Virion?

Wednesday, April 14 | 8:00AM - 11:00AM
HIV Genome RNA: From the Nucleus to the Plasma Membrane
Room: Ballroom C

Speaker 3 of 5
Casey D. Morrow, University of Alabama at Birmingham, USA
Selection of the tRNA Primer required for HIV Replication


Wednesday, April 14 | 8:00AM - 11:00AM
HIV Genome RNA: From the Nucleus to the Plasma Membrane
Room: Ballroom C

Speaker 4 of 5
Chantal Ehresmann, IBMC du Centre National de la Recherche Scientifique, France
The 5' -Untranslated Region of HIV-1 Genomic RNA: Structure and Functional Implications

Wednesday, April 14 | 8:00AM - 11:00AM
HIV Genome RNA: From the Nucleus to the Plasma Membrane
Room: Ballroom C

Speaker 5 of 5
James R. Williamson, The Scripps Research Institute, USA
Toward Inhibition of HIV Rev-RRE Interactions: Challenges for Targeting RNA

Wednesday, April 14 | 8:00AM - 9:30AM
Current Issues in the Clinical Evaluation of Vaccines
This session is from HIV Vaccine
Room: Ballroom B

Speaker 1 of 3
John W. Shiver, Sanofi Pasteur, USA
Development of an HIV-1 Vaccine Based on Replication-Defective Adenovirus


Wednesday, April 14 | 8:00AM - 9:30AM
Current Issues in the Clinical Evaluation of Vaccines
This session is from HIV Vaccine
Room: Ballroom B

Speaker 2 of 3
* Barney S. Graham, NIAID, National Institutes of Health, USA
Update of Trials of Multi-Clade DNA and Recombinant Adenovirus Vaccines


Wednesday, April 14 | 8:00AM - 9:30AM
Current Issues in the Clinical Evaluation of Vaccines
This session is from HIV Vaccine
Room: Ballroom B

Speaker 3 of 3
Lawrence Corey, Fred Hutchinson Cancer Research Center, USA
Update of HVTN Clinical Trials


Wednesday, April 14 | 9:20AM - 9:40AM
Coffee Break
Room: Grand Foyer


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 1 of 8
* Gary J. Nabel, Sanofi, USA


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 2 of 8
Dennis R. Burton, The Scripps Research Institute, USA
Criteria for Neutralizing Antibody Responses


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 3 of 8
Hana Golding, US Food and Drug Administration, USA
Regulatory Perspective


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 4 of 8
Emilio A. Emini, Bill and Melinda Gates Foundation, USA
Manufacturer's Perspective


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 5 of 8
John G. McNeil, Sanofi-Pasteur, USA
Clinical Perspective


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 6 of 8
Steve G. Self, Fred Hutchinson Cancer Research Center, USA
Statistical Perspective


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 7 of 8
Andrew J. McMichael, Oxford University, UK
Criteria for T Cell Responses


Wednesday, April 14 | 9:50AM - 11:30AM
Roundtable Discussion: Immunogenicity Criteria for Advancing
Candidate Vaccines into Phase III Trials
This session is from HIV Vaccine
Room: Ballroom B

Speaker 8 of 8
John P. Moore, Weill Medical College of Cornell University, USA
Criteria for Neutralizing Antibody Responses


Wednesday, April 14 | 11:00AM - 1:00PM
Poster Setup
Room: Ballroom A, Grand Foyer


Wednesday, April 14 | 1:00PM - 10:00PM
Poster Viewing
Room: Ballroom A, Grand Foyer


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 1 of 9
* Michael H. Malim, King's College London, UK

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 2 of 9
Vincent Piguet, Cardiff University, UK
DC-SIGN-Mediated Infectious Synapse Formation Enhances Transfer of HIV Infection from Dendritic Cells to T Cells

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 3 of 9
Clare Jolly, University College London, UK
HIV-1 Exploits an Env-Induced Synapse in CD4+ T Cells

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 4 of 9
Philippe Gallay, The Scripps Research Institute, USA
A Highly Conserved Arginine in the V3 Loop of Gp120 Governs HIV-1 Binding to Coreceptors and Syndecans

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 5 of 9
Teunis B.H. Geijtenbeek, University of Amsterdam, Netherlands
Mechanisms of DC-Sign Mediated Function in HIV-1 Infection

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 6 of 9
Rahm Gummuluru, Boston University School of Medicine, USA
Mechanism of DC-SIGN Mediated HIV-1 Transmission

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 7 of 9
David McDonald, National Institute of Allergy and Infectious Disease, USA
Enhancement of HIV Infection by Activated Dendritic Cells Occurs via
Trafficking through a CD81 Enriched Compartment


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 8 of 9
Ann-Marie M. Roy, University of California, San Francisco, USA
Impact of Coreceptor Use on HIV-1 Viral Output per Infected Cell

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: The Viral Synapse
Room: Ballroom C

Speaker 9 of 9
John Wilkinson, Westmead Millennium Institute, Australia
Increased HIV-1 Uptake in Immature Dendritic Cells and Increased Viral Transfer to CD4+ T Cells as a Result of Inhibition of the Endosomal - Lysosomal Degradation Pathway

Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 1 of 7
* Luis J. Montaner, Wistar Institute, USA


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 2 of 7
David Favre, GlaxoSmithKline, USA
Generation of Dysfunctional CD8+ T Cells in the Setting of HIV Infection


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 3 of 7
Daniel E. Kaufmann, University of Montreal, Canada
Promiscuous Presentation of the Same Epitopes by Different HLA Class II Alleles and Clustering of Overlapping Epitopes both Contribute to the High Frequency of Recognition by CD4 Cells of a Limited Subset of Gag and Nef HIV-1 Peptides


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 4 of 7
Christian Brander, Institut de Recerca de la Sida, IrsiCaixa, Spain
HLA-B63 (B*1516/B*1517) Presents HLA-B57 Restricted CTL Epitopes and is Associated with Slow HIV Disease Progression


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 5 of 7
Marie-Claire E. Gauduin, Texas Biomedical Research Institute, USA
Depletion of CD8+ Lymphocytes Results in Rebound Viremia in SIV-Infected Macaques with Undetectable Viral Replication following Early Antiretroviral Therapy


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 6 of 7
David A. Garber, Emory University, USA
Enhancing the Immunogenicity of MVA-based AIDS Vaccines


Wednesday, April 14 | 2:00PM - 4:00PM
Workshop 2: Immunobiology of HIV Infection
This session is from HIV Vaccine
Room: Ballroom B

Speaker 7 of 7
Shan Lu, University of Massachusetts Medical Center, USA
Immunogenicity of Monovalent and Polyvalent DNA Prime/Protein Boost Formulations Encoding Primary HIV-1 Env Antigens as Tested in Rabbits and Non-Human Primate Models


Wednesday, April 14 | 4:30PM - 4:45PM
Coffee & Snacks Available
Room: Grand Foyer


Wednesday, April 14 | 4:45PM - 7:15PM
Immediate Early Steps in Viral Entry and Uncoating
Room: Ballroom C

Speaker 1 of 5
* John P. Moore, Weill Medical College of Cornell University, USA
Effect of a Small Molecule CCR5 Inhibitor on Virus Infection in the Rhesus Macaque

Wednesday, April 14 | 4:45PM - 7:15PM
Immediate Early Steps in Viral Entry and Uncoating
Room: Ballroom C

Speaker 2 of 5
John A. T. Young, F.Hoffmann-La Roche Ltd, Switzerland
Cellular Factor Requirement in HIV-1 Uncoating Revealed by a Cell-Free System

Wednesday, April 14 | 4:45PM - 7:15PM
Immediate Early Steps in Viral Entry and Uncoating
Room: Ballroom C

Speaker 3 of 5
Christopher Aiken, Vanderbilt University School of Medicine, USA
Capsid Disassembly and HIV-1 Infection

Wednesday, April 14 | 4:45PM - 7:15PM
Immediate Early Steps in Viral Entry and Uncoating
Room: Ballroom C

Speaker 4 of 5
Thomas J. Hope, Northwestern University, USA
HIV Entry and Early Events (Cytoplasmic Trafficking)

Wednesday, April 14 | 4:45PM - 7:15PM
Immediate Early Steps in Viral Entry and Uncoating
Room: Ballroom C

Speaker 5 of 5
Vineet N. KewalRamani, NCI, National Institutes of Health, USA
Cell and Molecular Requirements for DC-SIGN-Mediated HIV Transmission

Wednesday, April 14 | 4:45PM - 7:00PM
Advances in Immunobiology
This session is from HIV Vaccine
Room: Ballroom B

Speaker 1 of 4
Arlene H. Sharpe, Harvard Medical School, USA
Current Understanding of Immune Co-Stimulation


Wednesday, April 14 | 4:45PM - 7:00PM
Advances in Immunobiology
This session is from HIV Vaccine
Room: Ballroom B

Speaker 2 of 4
* Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Induction and Maintenance of Serological Memory


Wednesday, April 14 | 4:45PM - 7:00PM
Advances in Immunobiology
This session is from HIV Vaccine
Room: Ballroom B

Speaker 3 of 4
Jonathan W. Yewdell, NIAID, National Institutes of Health, USA
Induction of TCD8+ Responses by Viruses


Wednesday, April 14 | 4:45PM - 7:00PM
Advances in Immunobiology
This session is from HIV Vaccine
Room: Ballroom B

Speaker 4 of 4
Eli Gilboa, University of Miami, Miller School of Medicine, USA
Therapeutic Vaccination with mRNA Transfected Dendritic Cells for Cancer and Infectious Diseases


Wednesday, April 14 | 7:00PM - 8:00PM
Social Hour
Room: Ballroom A, Grand Foyer


Wednesday, April 14 | 7:30PM - 10:00PM
Poster Session 2
Room: Ballroom A, Grand Foyer


Thursday, April 15 | 6:30AM - 8:00AM
Breakfast
Room: Lower Level


Thursday, April 15 | 8:00AM - 11:30AM
Innate Intracellular Antiviral Responses (Joint)
Room: Ballroom B, C

Speaker 1 of 6
Michael H. Malim, King's College London, UK
VIF and the Evasion of Host-Mediated Viral cDNA Deamination

Thursday, April 15 | 8:00AM - 11:30AM
Innate Intracellular Antiviral Responses (Joint)
Room: Ballroom B, C

Speaker 2 of 6
Warner Craig Greene, Gladstone Institute of Virology and Immunology, USA
HIV Vif versus the Antiviral APOBEC3G Enzyme: New Insights into the Mechanism of Vif Action

Thursday, April 15 | 8:00AM - 11:30AM
Innate Intracellular Antiviral Responses (Joint)
Room: Ballroom B, C

Speaker 3 of 6
Didier Trono, Ecole Polytechnique Fédérale de Lausanne, Switzerland
Innate Intracellular defenses Against Retroelements


Thursday, April 15 | 8:00AM - 11:30AM
Innate Intracellular Antiviral Responses (Joint)
Room: Ballroom B, C

Speaker 4 of 6
* Stephen P. Goff, Columbia University, USA
Cellular Blocks to HIV and MuLV Infection

Thursday, April 15 | 8:00AM - 11:30AM
Innate Intracellular Antiviral Responses (Joint)
Room: Ballroom B, C

Speaker 5 of 6
Jonathan P. Stoye, Francis Crick Institute, UK
Fv1 and Related Retrovirus Restriction Genes

Thursday, April 15 | 8:00AM - 11:30AM
Innate Intracellular Antiviral Responses (Joint)
Room: Ballroom B, C

Speaker 6 of 6
Jaisri R. Lingappa, University of Washington, USA
HP68/RNase L Inhibitor: A Host Factor Critical for Virion Assembly

Thursday, April 15 | 9:20AM - 9:40AM
Coffee Break
Room: Grand Foyer


No content found

No content found

No content found